Iovance Biotherapeutics

Iovance Biotherapeutics is a clinical-stage biotechnology company focused on developing and commercializing novel cancer immunotherapies. They are pioneering the development of tumor-infiltrating lymphocyte (TIL) therapy, a personalized approach that harnesses the power of a patient's own immune system to fight cancer. Iovance is dedicated to bringing innovative and life-changing treatments to patients with solid tumors.